{
    "applicationNumber": "BR 11 2022 025435-0",
    "filingDate": "24/06/2021",
    "grantDate": null,
    "title": "DERIVADOS DE QUINOXALINA COMO F\u00c1RMACOS ANTIC\u00c2NCER",
    "nationalPhaseDate": [
        "13/12/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT EP2021/067304",
        "pctDate": "24/06/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "63/044,095",
            "priorityDate": "25/06/2020"
        },
        {
            "countryCode": "US",
            "priorityNumber": "63/120,351",
            "priorityDate": "02/12/2020"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2711"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2716"
        }
    ],
    "inventors": [
        "MARTIN JOHN PACKER",
        "SEBASTIEN LOUIS DEGORCE",
        "JEFFREY WALLACE JOHANNES",
        "SUDHIR MAHADEO HANDE",
        "AVIPSA GHOSH",
        "XIAOLAN ZHENG"
    ],
    "holders": [
        79506
    ],
    "ipcCodes": [
        "A61P 35/00",
        "C07D 401/12",
        "A61K 31/496"
    ]
}